| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/05/2006 | US20060003949 Freeze-dried preparation of stabilized anthracycline compound |
| 01/05/2006 | US20060003946 Tissue-penetrating property, and exhibits high selectivity to tumor cells and hydrophilicity |
| 01/05/2006 | US20060003919 Cosmetic/dermatological applications of LIF |
| 01/05/2006 | US20060003916 Parathyroid hormone-related protein (PTHrP) specific antibodies for targeted treatment of kidney, liver and/or lung specic cell proliferative disorders; Antitumor agents |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 01/05/2006 | US20060003063 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | US20060002966 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| 01/05/2006 | US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators) |
| 01/05/2006 | US20060002908 Bifidobacterium in the treatment of inflammatory disease |
| 01/05/2006 | US20060002905 Mutant forms of EtxB and CtxB and their use as carriers |
| 01/05/2006 | US20060002897 Plasmid for tissue targeted treatment of tumors; antitumor agents |
| 01/05/2006 | US20060002893 Targeted adenovirus vectors for delivery of heterologous genes |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | DE102004029784A1 Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel New 2-Benzylaminodihydropteridinone, process for their preparation and their use as medicaments |
| 01/05/2006 | CA2584493A1 Kinase inhibitors for treating cancers |
| 01/05/2006 | CA2578592A1 Conjugates and therapeutic uses thereof |
| 01/05/2006 | CA2572328A1 2-aminoarylcarboxamides useful as cancer chemotherapeutic agents |
| 01/05/2006 | CA2571990A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides |
| 01/05/2006 | CA2571852A1 Inhibition of infiltration, and cell killing agent |
| 01/05/2006 | CA2571849A1 Anticancer agent containing dendritic cell having rna virus transferred thereinto |
| 01/05/2006 | CA2571844A1 Anticancer agent containing minus-strand rna virus |
| 01/05/2006 | CA2571421A1 Compounds for immunopotentiation |
| 01/05/2006 | CA2571419A1 A preparation comprising batroxobin for inhibiting local invasion of malignant tumors |
| 01/05/2006 | CA2571002A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 01/05/2006 | CA2570873A1 Pyrimidine urea derivatives as kinase inhibitors |
| 01/05/2006 | CA2570552A1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 01/05/2006 | CA2566991A1 Malignant tumor-inhibiting preparation comprising des a fibrin |
| 01/05/2006 | CA2547979A1 Process for the preparation of anastrozole |
| 01/04/2006 | EP1612281A2 Methods for assessing patients with acute myeloid leukemia |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612225A1 Modified acacia and use thereof |
| 01/04/2006 | EP1612215A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/04/2006 | EP1612208A2 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611889A1 Antibacterial agent and anticancer agent |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611885A1 Use of an inducing agent for the treatment of blood, viral and cellular disorders |
| 01/04/2006 | EP1611156A2 Neoplasm specific antibodies and uses thereof |
| 01/04/2006 | EP1611151A2 Stq-peptides |
| 01/04/2006 | EP1611143A2 New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 01/04/2006 | EP1611137A1 Salts of tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/04/2006 | EP1611136A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 01/04/2006 | EP1611125A1 Heteroaryl substituted pyrolls useful as inhibitors of protein kinases |
| 01/04/2006 | EP1611123A2 Tie-2 modulators and methods of use |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1611112A1 Isoxazole compounds as inhibitors of heat shock proteins |
| 01/04/2006 | EP1611105A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| 01/04/2006 | EP1610824A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 01/04/2006 | EP1610818A1 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 01/04/2006 | EP1610806A2 Method of treating cancer with azaspirane compositions |
| 01/04/2006 | EP1610795A2 Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs |
| 01/04/2006 | EP1610793A2 Thiazoles useful as inhibitors of protein kinases |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1610774A2 Tie-2 modulators and methods of use |
| 01/04/2006 | EP1534744A4 Altered insulin-like growth factor binding proteins |
| 01/04/2006 | EP1434762A4 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1366082B1 Highly sulfated derivatives of k5 polysaccharide and their preparation |
| 01/04/2006 | EP1311677B1 Regulation of human p2y1-like g protein-coupled receptor |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1250422B1 Myeloid colony stimulating factor and uses thereof |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
| 01/04/2006 | EP1150995B1 A synthetic peptide disturbing intracellular signaling |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP1146881B1 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
| 01/04/2006 | EP1083898B1 Novel use of hiv protease inhibiting compounds |
| 01/04/2006 | EP1077728B1 Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy |
| 01/04/2006 | EP1053325B1 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination |
| 01/04/2006 | EP1019518B1 Self-deleting vectors for cancer therapy |
| 01/04/2006 | EP0977562B1 Methods and compositions for delivery of taxanes |
| 01/04/2006 | EP0932399B1 Water soluble paclitaxel prodrugs |
| 01/04/2006 | CN1717493A Process for producing macrolide compound |
| 01/04/2006 | CN1717396A Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 01/04/2006 | CN1717239A Transdermal therapeutic system containing testosterone and method for the production thereof |
| 01/04/2006 | CN1717228A Pharmaceutical composition comprising a LTB4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 01/04/2006 | CN1715298A Ganodema tsugae-proteoglycan and its preparing method and use |
| 01/04/2006 | CN1715296A Recombinant human mannan-binding lectin |
| 01/04/2006 | CN1715293A Ganoderma tsugae-proteoglycan mixture and its preparing method and use |
| 01/04/2006 | CN1715292A Cerbera manghas heteroside derivative, its preparing method and use |
| 01/04/2006 | CN1715290A Dengxin subergorgia saponin |
| 01/04/2006 | CN1715284A Synthetic method for organic germanium naphthol ester and organic germanuim anthraquinone amide compound |
| 01/04/2006 | CN1715283A Novel garcinolic acid derivative and its preparing method and use |
| 01/04/2006 | CN1715269A Cyanopyrrolidine derivatives |
| 01/04/2006 | CN1714871A Use of human ING4 gene as chemotherapy medicine sensitivity promoter |
| 01/04/2006 | CN1714870A Use of human homology cassette gene LHX4 in preparing medicine for treating phaeochromocytoma |
| 01/04/2006 | CN1714868A Composition and method for reducing side effects of indole-3-carbinol and derivatives |
| 01/04/2006 | CN1714863A Method for extracting curcin and its use |
| 01/04/2006 | CN1714862A Liver cancer relative gene DLK1 and its use |
| 01/04/2006 | CN1714792A Composition of epigallocatechin, gallate and folic acid and its use |
| 01/04/2006 | CN1714785A Concentrated emulsifier containing taxol compound and its using method |
| 01/04/2006 | CN1234852C False virosome vaccine with recombinant replica of dengue fever virus as carrier |
| 01/04/2006 | CN1234851C Vaccine for human papilloma virus |
| 01/04/2006 | CN1234727C Human thymosin alpha protogene mutant synthesis, expression and use |
| 01/04/2006 | CN1234711C Mikanolide derivatives,their preparation and its therapeutic uses |
| 01/04/2006 | CN1234707C Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science |